Carlo de Notaristefani
2018
Compensation breakdown
Non-Equity Incentive Plan | $1,495,232 |
---|---|
Option Awards | $1,166,679 |
Salary | $836,400 |
Stock Awards | $3,549,915 |
Other | $194,294 |
Total | $7,242,520 |
de Notaristefani received $3.5M in stock awards, accounting for 49% of the total pay in 2018.
de Notaristefani also received $1.5M in non-equity incentive plan, $1.2M in option awards, $836.4K in salary and $194.3K in other compensation.
Rankings
In 2018, Carlo de Notaristefani's compensation ranked 1,177th out of 14,244 executives tracked by ExecPay. In other words, de Notaristefani earned more than 91.7% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 1,177 out of 14,244 | 92nd |
Division Manufacturing | 401 out of 5,765 | 93rd |
Major group Chemicals And Allied Products | 124 out of 2,128 | 94th |
Industry group Drugs | 96 out of 1,817 | 95th |
Industry Pharmaceutical Preparations | 69 out of 1,391 | 95th |
de Notaristefani's colleagues
We found four more compensation records of executives who worked with Carlo de Notaristefani at Teva Pharmaceutical Industries in 2018.
2018
Kåre Schultz
Teva Pharmaceutical Industries
Chief Executive Officer
2018
Hafrun Fridriksdottir
Teva Pharmaceutical Industries
Executive Vice President, Global Research and Development
2018
Mark Sabag
Teva Pharmaceutical Industries
Executive Vice President, Global Human Resources
2018
Michael McClellan
Teva Pharmaceutical Industries